These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19857586)

  • 1. Myelodysplastic syndromes: from neglect to prominence.
    Deeg HJ
    Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S28-9. PubMed ID: 19857586
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in MDS.
    Schiffer CA
    Clin Adv Hematol Oncol; 2007 Jun; 5(6):450-2. PubMed ID: 17679919
    [No Abstract]   [Full Text] [Related]  

  • 3. Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges.
    Shah NN; Bacher U; Fry T; Calvo KR; Stetler-Stevenson M; Arthur DC; Kurlander R; Baird K; Wise B; Giralt S; Bishop M; Hardy NM; Wayne AS
    Am J Hematol; 2012 Sep; 87(9):916-22. PubMed ID: 22473867
    [No Abstract]   [Full Text] [Related]  

  • 4. Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality.
    Del Galy AS; Marouf A; Raffoux E; Robin M; Michonneau D; Sébert M; Sicre de Fontebrune F; Xhaard A; Lengline E; Itzykson R; Frieri C; Dombret H; Fenaux P; Peffault de Latour R; Adès L; Socié G
    Leukemia; 2021 Jan; 35(1):225-228. PubMed ID: 32733010
    [No Abstract]   [Full Text] [Related]  

  • 5. Unusual course of myelodysplastic syndrome with presumed familial origin.
    Bacher U; Ocheni S; Schafhausen P; Oyekunle A; Dierlamm J; Zander AR; Bokemeyer C; Haferlach T; Kröger N
    Acta Haematol; 2011; 126(4):234-7. PubMed ID: 21952642
    [No Abstract]   [Full Text] [Related]  

  • 6. Diabetes insipidus in myelodysplastic syndrome: what we learnt from a case regarding its diagnosis, pathophysiology and management.
    Chuang C; Parnerkar V; Radulescu A; Hunt MA; Cayci Z; Ustun C
    Leuk Lymphoma; 2015 Apr; 56(4):1134-6. PubMed ID: 25039352
    [No Abstract]   [Full Text] [Related]  

  • 7. Myelodysplasia.
    Heaney ML; Golde DW
    N Engl J Med; 1999 May; 340(21):1649-60. PubMed ID: 10341278
    [No Abstract]   [Full Text] [Related]  

  • 8. Prognostic impact of serum CXC chemokine ligands 4 and 7 on myelodysplastic syndromes post allogeneic hematopoietic cell transplant.
    Dhakal B; Wang T; Kuxhausen M; Zhu F; Taylor C; Spellman SR; Verneris MR; Hsu K; Fleischhauer K; Lee SJ; Bolon YT; Carlson KS; Nazha A; Saber W
    Leuk Lymphoma; 2021 Jan; 62(1):229-233. PubMed ID: 32924688
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of myelodysplastic syndromes: just the beginning.
    Kim H; Garcia-Manero G
    Oncology (Williston Park); 2008 Nov; 22(12):1360, 1363, 1368. PubMed ID: 19320068
    [No Abstract]   [Full Text] [Related]  

  • 10. JSH practical guidelines for hematological malignancies, 2018: I. Leukemia-6 myelodysplastic syndromes (MDS).
    Miyazaki Y
    Int J Hematol; 2020 Apr; 111(4):481-493. PubMed ID: 32060786
    [No Abstract]   [Full Text] [Related]  

  • 11. Myelodysplastic syndromes.
    Scott BL; Deeg HJ
    Annu Rev Med; 2010; 61():345-58. PubMed ID: 20059342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The message is not the median!
    Deeg HJ
    Mayo Clin Proc; 2004 Feb; 79(2):275; author reply 275-6. PubMed ID: 14959926
    [No Abstract]   [Full Text] [Related]  

  • 13. Flying without a net in MDS.
    Sekeres MA
    Blood; 2013 Oct; 122(17):2925-6. PubMed ID: 24159163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelodysplastic syndromes clinical practice guidelines in oncology.
    Greenberg PL; Baer MR; Bennett JM; Bloomfield CD; De Castro CM; Deeg HJ; Devetten MP; Emanuel PD; Erba HP; Estey E; Foran J; Gore SD; Millenson M; Navarro WH; Nimer SD; O'Donnell MR; Saba HI; Spiers K; Stone RM; Tallman MS
    J Natl Compr Canc Netw; 2006 Jan; 4(1):58-77. PubMed ID: 16403405
    [No Abstract]   [Full Text] [Related]  

  • 15. Selection of Patients With Myelodysplastic Syndrome for Allogeneic Hematopoietic Stem Cell Transplantation.
    Mishra A; Anasetti C
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S49-52. PubMed ID: 27521324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic stem cell transplantation in a patient with myelodysplastic syndrome and polyarteritis nodosa: a case report and systematic review.
    Stavenga M; Leavis HL; de Witte TM; Raymakers RA
    Ann Hematol; 2016 Mar; 95(4):645-7. PubMed ID: 26787416
    [No Abstract]   [Full Text] [Related]  

  • 17. Pediatric myelodysplastic syndromes.
    Niemeyer CM; Kratz CP; Hasle H
    Curr Treat Options Oncol; 2005 May; 6(3):209-14. PubMed ID: 15869732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seventh International Symposium on Myelodysplastic Syndromes.
    Yoshida Y
    Int J Hematol; 2003 Oct; 78(3):272-5. PubMed ID: 14604291
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M.
    Gurnari C; Gagelmann N; Badbaran A; Awada H; Dima D; Pagliuca S; D'Aveni-Piney M; Attardi E; Voso MT; Cerretti R; Wolschke C; Rubio MT; Maciejewski JP; Kröger N
    Leukemia; 2023 Mar; 37(3):717-719. PubMed ID: 36709353
    [No Abstract]   [Full Text] [Related]  

  • 20. Success of haploidentical hematopoietic stem cells transplantation in the treatment of graft failure.
    Pagliuca S; Legendre H; Morin S; Rabian F; Naveau L; Zine M; Wang L; Marchand T; Coman T; Xhaard A; Ferry C; Robin M; Peffault De Latour R; Socié G; Sicre de Fontbrune F
    Ann Hematol; 2016 Jan; 95(2):353-4. PubMed ID: 26471035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.